Raisio and Dr. Schär signed a strategic alliance

Udgivet den 07-03-2019  |  kl. 06:30  |  

Raisio plc, Press Release, 7 March 2019

RAISIO AND DR. SCHÄR SIGNED A STRATEGIC ALLIANCE

Raisio has signed an agreement on a strategic alliance with the Italian company Dr. Schär AG. Dr. Schär is a leading global company in gluten-free foods while Raisio is a forerunner in cholesterol-lowering functional foods and an innovative expert in Finnish oats. Combined expertise of the companies opens new commercial opportunities for both.

The long-term framework agreement now signed outlines the essential contents of the strategic alliance. The companies are exploring opportunities for extensive collaboration in product development and manufacturing, among other things.

Raisio and Dr. Schär see that this strategic alliance creates added value for both companies. The collaboration also opens new opportunities for Raisio's Benecol and Elovena brands, in Dr. Schär's strong markets, particularly in Germany, Italy, France and Spain.

Raisio's President and CEO Pekka Kuusniemi: "With its clear focus and high expertise in the markets of value-added products, Dr. Schär is an excellent partner for Raisio. Dr. Schär's strong foothold in Europe complements Raisio's geographical presence."

Dr. Schär's CEO Ulrich Ladurner: "The strategic alliance with Raisio is an important step for us as it will enable us to further develop and strengthen our distribution network. In addition, Raisio's value brands will complete our portfolio and we will get access to Raisio's excellence in oats. As a family-owned company, it is important for us to know that the companies share the same core values."

Dr. Schär is a pioneer in developing gluten-free products since 1922. With its extensive experience and know-how in R&D and marketing, Dr. Schär is the world's leading company. Today, Dr. Schär products are available around the globe. Since 2014, Dr. Schär has expanded its area of activities by developing and commercialising special products in the field of medical nutrition. Dr. Schär has 1270 employees and 10 production plants. The net sales amounted to EUR 360 million in 2018.


RAISIO PLC

Pekka Kuusniemi
President and CEO
tel. +358 50 537 3883


Raisio plc

Raisio is an international company specialised in healthy, responsibly produced food. Our well-known brands include, for example, Benecol, Elovena, Nalle and Sunnuntai. In Raisio's products, the focus is on well-being, health, good taste and sustainable development. Profitable growth is ensured through our strong expertise and passion for creating new. Raisio's shares are listed on Nasdaq Helsinki Ltd. In 2018, the Group's net sales for continuing operations totalled EUR 228 million and comparable EBIT was EUR 26 million. Our food is good for Health, Heart and Earth. For more information on Raisio go to www.raisio.com.

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

10:30 Europæiske naturgaspriser falder for tredje dag i træk
09:59 Chicago-børs flytter til Texas i forsøg på at skabe en ny finansiel hovedstad
09:19 Tyske prisstigninger aftager efter måneder med inflationshop
09:14 Aktier/åbning: Genmab tordner i vejret efter regnskab
09:04 Genmab går frem i de første handler efter regnskab
08:56 Obligationer/åbning: Mindre rentefald forud for nye pristal
08:37 Japanske bilgiganter Honda og Nissan dropper fusion - NY1
08:33 Finsk FLS-konkurrent overrasker med højere udbytte end ventet
08:28 NNIT/SEB: Kursmål sænkes til 121 kr. fra 153 kr. af SEB - fastholder "køb"
08:27 Britisk økonomi voksede overraskende i fjerde kvartal
08:18 Råvarer: Oliepriserne falder efter en potentiel fredsaftale mellem Rusland og Ukraine
08:06 Aktier/tendens: Grøn dag i sigte på øget fredshåb med fokus på regnskabsaktuelle Genmab
07:13 Obligationer/tendens: Mindre rentefald i sigte med øjnene rettet mod nye pristal
07:07 Asien: Håb om Ukraine-fred sender asiatiske aktier og amerikanske futures op
06:35 Genmab planlægger tilbagekøb af omkring 1,9 mio. egne aktier
06:35 Genmabs topchef om vigtig partnerafgørelse: Langsigtede investorer sidder på deres hænder
06:35 Genmab/Sydbank: Stærk prognose og flot bundlinje men option spøger stadig
06:35 Genmabs guldæg slår forventningerne - bundlinjen klart bedre end forudset
06:32 Asien: Håb om Ukraine-fred sender asiatiske aktier og amerikanske futures op
06:32 Valuta: Amerikansk inflation og politik præger handlen